Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Enveda, a company using artificial intelligence to boost nature-based drug discovery, is envisioning clinical success with a ...

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it's never quite as straightforward to ...

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Short interest in SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) decreased during the last reporting period, falling from 56.89M to 55.94M. This put -% of the company's publicly available ...

Lift BioSciences has announced the opening of a new subsidiary in Co Galway, Ireland to further develop its tumour treatments.

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

The retail giant's CEO, Doug McMillon, started working for the company in high school, eventually rising to CEO in 2014. Here ...